The same observation has been achieved in lung adenocarcinoma (LUAD) where eEF2K is typically overexpressed to promotes the migration, invasion, and angiogenesis of LUAD cells, thereby driving tumor progression18. Here, EEF2K is linked to lung adenocarcinoma.